Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

ClinicalTrials.gov ID: NCT01175226

Public ClinicalTrials.gov record NCT01175226. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 1:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to evaluate the safety, tolerability and effectiveness of BTA798 on * shortening the length and reducing the symptoms of human rhinovirus infection (also known as the common cold), * controlling asthma symptoms, and * lowering the risk of asthma symptoms worsening in subjects with asthma.

Study identification

NCT ID
NCT01175226
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Feb 29, 2012
Completion
Feb 29, 2012
Last update posted
May 30, 2018

2010 – 2012

United States locations

U.S. sites
43
U.S. states
23
U.S. cities
39
Facility City State ZIP Site status
Research Site Scottsdale Arizona 85251
Research Site Little Rock Arkansas 72205
Research Site Fountain Valley California 92708
Research Site Orange California 92868
Research Site Waterbury Connecticut 06709
Research Site Hialeah Florida 33016
Research Site Bangor Maine 04401
Research Site Baltimore Maryland 21236
Research Site Bethesda Maryland 20814
Research Site Boston Massachusetts 02115
Research Site St Louis Missouri 63141
Research Site Omaha Nebraska 68130
Research Site Omaha Nebraska 68134
Research Site Papillion Nebraska 68046
Research Site Albuquerque New Mexico 87108
Research Site New York New York 10016
Research Site Newburgh New York 12550
Research Site North Syracuse New York 13212
Research Site Rockville Centre New York 11570
Research Site Asheville North Carolina 28801
Research Site Raleigh North Carolina 27612
Research Site Fargo North Dakota 58103
Research Site Cincinnati Ohio 45242
Research Site Cincinnati Ohio 45267
Research Site Oklahoma City Oklahoma 73120
Research Site Oklahoma City Oklahoma 73131
Research Site Lake Oswego Oregon 97035
Research Site Medford Oregon 97504
Research Site Hershey Pennsylvania 17033
Research Site Philadelphia Pennsylvania 19115
Research Site Pittsburgh Pennsylvania 15221
Research Site Pittsburgh Pennsylvania 15241
Research Site Upland Pennsylvania 19013
Research Site East Providence Rhode Island 02914
Research Site Lincoln Rhode Island 02865
Research Site Providence Rhode Island 02906
Research Site San Antonio Texas 78229
Research Site Waco Texas 76712
Research Site South Burlington Vermont 05403
Research Site Richmond Virginia 23229
Research Site Greenfield Wisconsin 53228
Research Site Madison Wisconsin 53792
Research Site West Allis Wisconsin 53227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01175226, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 30, 2018 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01175226 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →